• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Smartphone Photos to Detect Anemia

      Smartphone Photos to Detect Anemia

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

      Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

    • Radiology
      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

      Terahertz Spectroscopy to Assess Severity of Skin Burns

      Terahertz Spectroscopy to Assess Severity of Skin Burns

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Fibrosarcoma Drugs Market is Estimated to Augment Growth by 2028 | Bristol-Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Baxter International

January 13th, 2022 Coherent Market Insights Releases

Fibrosarcoma is a rare type of soft tissue malignant tumor composed solely of fiber-forming connective tissue called fibroblasts. Although this condition can occur at any age, it is commonly diagnosed between the age of 30-60 years. Individuals, who are suffering from genetic health conditions such as nevoid basal cell carcinoma syndrome, retinoblastoma, are more prone to have fibrosarcoma. However, the precise cause of the disease is unknown. Individuals going through radiation treatment or suffering from lymphedema or getting exposed to chemicals such as arsenic, or thorium dioxide vinyl chloride are more likely to suffer from fibrosarcoma. This disease is symptomized by muscular pain, which increases exponentially with time. It is diagnosed by bone lesions in the radiograph, followed by advanced imaging and laboratory test and confirmed by biopsy results. Treatment of the disease depends on the stage of the tumor during diagnosis. Surgery and radiation therapy are the treatment used for fibrosarcoma.  Currently, a limited number of treatment methods and various side effects of chemotherapy such as hair loss or low blood platelet count are propelling demand for research and development activities in fibrosarcoma treatment.

Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/1495

Fibrosarcoma Drugs Market Driver

Increasing research activities are expected to fuel the growth of the fibrosarcoma drugs market over the forecast period. Fibrosarcoma being a malignant tumor requires early removal through complete eradication of malignant cells by chemotherapy. Currently, available chemotherapy includes side effects such as acquiring multi-drug resistance (MDR), severe side effects, and a high rate of reoccurrence, which in turn demands a safer drug for chemotherapy.

For instance, Loxo Oncology Inc., 2017, received US FDA approval for an investigational new drug application for LOXO 195, a next-generation TRK inhibitor for treating individuals suffering from cancers that have acquired resistance to primary TRK therapy such as larotrectinib. Moreover, in the same year, LOXO oncology announced a partnership with Bayer for the global development and commercialization of Larotrectinib and LOXO-195. The novel drug combination studies, a clinical trial for targeted drug delivery, and genetic profile-based medication are expected to boost the growth of the fibrosarcoma drugs market over the forecast period.

The increasing prevalence of fibrosarcoma is expected to augment the growth of the fibrosarcoma drugs market. According to the American Society of Clinical Oncology, 2017, around 3260 individuals were diagnosed with primary bone cancer in the U.S. out of which 4% of adults are suffering from fibrosarcoma, and the prevalence of the disease is higher in men than in women. Currently, the diagnosis facility lacks in early and accurate detection of fibrosarcoma. Therefore, raising awareness for disease and advancement in diagnostic as well as therapeutic procedures are expected to propel the growth of the fibrosarcoma drugs market.

Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/1495

Furthermore, companies, universities, and institutes are taking initiatives to provide inexpensive, readily available drugs with fewer side-effects as compared to present drugs that will help key players to strengthen product portfolio, in turn driving the growth of the fibrosarcoma drug market. Key players, as well as government organizations such as the Nation Cancer Institute or American Society of Clinical Oncology, sponsors or collaborate for the development of novel therapies and drugs. For instance, Bayer partners with loxo oncology to develop and commercialize cancer treatments. Bristol-Myers Squibb Company took over IFM Therapeutics, 2017, to have right on preclinical stimulator of interferon genes (STING) and NLRP3 agonist programs. This is focused on advancing the innate immune response for tumors.

Fibrosarcoma Drugs Market- Regional Analysis

The global fibrosarcoma market is projected to hold a dominant position in North America over the forecast period, due to increasing research activities leading to better fibrosarcoma treatment. Furthermore, well-developed healthcare infrastructure is fuelling the growth of the fibrosarcoma market. The Asia Pacific is expected to be the fastest-growing market over the forecast period due to developing healthcare infrastructure and rising awareness regarding conditions of fibrosarcoma.

Fibrosarcoma Drugs Market- Competitor

Major players operating in the fibrosarcoma drugs market include Celon Laboratories Pvt. Ltd., Johnson & Johnson., Pfizer Limited, Eli Lilly and Company, Baxter International Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, and Cadila Healthcare Limited.

Reasons to Buy this Fibrosarcoma Drugs Market Report

➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Fibrosarcoma Drugs market

➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Fibrosarcoma Drugs market

➡Leading company profiles reveal details of key Fibrosarcoma Drugs market players emerging five operations and financial performance

➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Fibrosarcoma Drugs market with five year historical forecasts

➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .

Buy This Complete Business Report With Flat USD 2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1495

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Fibrosarcoma Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Fibrosarcoma Drugs Industry Impact

Chapter 2 Global Fibrosarcoma Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Fibrosarcoma Drugs (Volume and Value) by Type
2.3 Global Fibrosarcoma Drugs (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Fibrosarcoma Drugs Sales, Consumption, Export, Import by Regions
Chapter 5 North America Fibrosarcoma Drugs Market Analysis
Chapter 6 East Asia Fibrosarcoma Drugs Market Analysis
Chapter 7 Europe Fibrosarcoma Drugs Market Analysis
Chapter 8 South Asia Fibrosarcoma Drugs Market Analysis
Chapter 9 Southeast Asia Fibrosarcoma Drugs Market Analysis
Chapter 10 Middle East Fibrosarcoma Drugs Market Analysis
Chapter 11 Africa Fibrosarcoma Drugs Market Analysis
Chapter 12 Oceania Fibrosarcoma Drugs Market Analysis
Chapter 13 South America Fibrosarcoma Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Fibrosarcoma Drugs Business
Chapter 15 Global Fibrosarcoma Drugs Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

interviews & reviews
Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email